Topic: academic partnership
The creation of the latest outpost of the BRIDGE model sees Evotec team up with Integra Holdings and Yissum to help researchers at Hebrew University.
NCATS aims to bring together disparate data sets from across the healthcare enterprise to communicate the patient's story in a different way.
The consortium intends to make new tools, models and processes broadly available, with a large focus on solutions geared toward cancer patients.
The agreement will give Bayer the chance to explore drug targets based on research at a leading Japanese scientific research institute.
The partners will work out of a joint lab at Brigham and Women's Hospital in Boston that will receive more than $30 million over the next five years.
Weeks after getting off a major $110 million series B round, well-funded Passage Bio has grabbed a new C-suite member on top of its cash haul.
Working with Sensyne Health, Evotec will support researchers at the university as they generate data to show the commercial viability of projects.
GlaxoSmithKline is joining forces with the University of California to dig into how gene mutations cause disease and use CRISPR to discover new drugs.
The $130 million is to be funneled over a 10-year period through a new company borne of the alliance known as Hudson Heights Innovations.
Tmunity Therapeutics has licensed a T-cell receptor treatment from UCSF and aims to start human trials by 2021.